FDA data Registry peer set 6 peers FDA shortage listed

Alternatives to nortriptyline

FDA shortage status is active for nortriptyline; 6 same-class SPL records are listed below for registry comparison only.

Brand: Pamelor

Tricyclic Antidepressant (TCA) Prescription 6 alternatives found

nortriptyline class peers while FDA lists an active shortage

nortriptyline (Pamelor) is on an FDA shortage listing while 6 other Tricyclic Antidepressant (TCA) SPL records remain in this registry peer set (class inventory 7). Labeled indication field for nortriptyline: Nortriptyline is used to relieve the symptoms of depression.

Top FAERS reaction fields for nortriptyline total 5,034 reports across 10 reactions, set beside amitriptyline, clomipramine, desipramine. Counts are exposure-weighted submissions, not per-patient risk.

About nortriptyline

Nortriptyline (Pamelor) is a medicine used to treat depression. It can help improve your mood.

Used for: Nortriptyline is used to relieve the symptoms of depression. It may work better for some types of depression than others. Talk to your doctor to see if nortriptyline is right for you.

6 Tricyclic Antidepressant (TCA) peers (wide set)

Compare nortriptyline vs amitriptyline side-by-side →

nortriptyline vs amitriptyline & clomipramine · FAERS reaction fields

FAERS top-reaction field "Nausea" shows the widest count spread between nortriptyline and amitriptyline, clomipramine, desipramine in this extract (921-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect nortriptyline amitriptylineclomipraminedesipramine
Pain 695 1,565 - 59
Headache 679 1,381 - 70
Fatigue 593 1,371 136 119
Nausea 513 1,434 173 77
Hyperhidrosis 485 - - -
Hypersensitivity 460 - - -
Drug Hypersensitivity 430 - - 42
Hypertension 396 - - -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

nortriptyline shortage vs Tricyclic Antidepressant (TCA) peer index

Shortage status

FDA shortage listing is active for nortriptyline (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for nortriptyline while peers remain indexed?
Yes - nortriptyline matched an active FDA shortage listing (To Be Discontinued) while 6 other Tricyclic Antidepressant (TCA) SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full nortriptyline profile →

Field note for nortriptyline: see also the generic vs brand label guide when reading Pamelor SPL strings.